The Trade Desk, Inc. (TTD)

Revance Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	42,087	58,010	35,282	21,945	44,045	37,618
Market Cap Growth	-36.49%	64.42%	60.77%	-50.18%	17.08%	220.84%
Enterprise Value	40,681	56,571	34,008	20,890	43,540	37,373
Last Close Price	86.08	117.53	71.96	44.83	91.64	80.10
PE Ratio	105.14	147.58	197.17	411.07	319.72	155.25
Forward PE	47.55	64.45	55.52	43.86	113.05	171.52
PS Ratio	16.50	23.73	18.13	13.91	36.81	45.00
PB Ratio	15.57	19.67	16.30	10.37	28.84	37.13
P/TBV Ratio	15.49	19.77	16.43	10.47	29.11	37.56
P/FCF Ratio	60.53	90.47	63.97	47.24	136.06	113.65
P/OCF Ratio	49.78	78.45	58.97	39.99	116.36	92.87
PEG Ratio	1.48	2.59	2.38	1.50	3.19	5.53
EV/Sales Ratio	15.83	23.14	17.48	13.24	36.39	44.70
EV/EBITDA Ratio	77.24	113.45	127.42	129.69	268.71	224.01
EV/EBIT Ratio	89.81	132.43	169.63	183.81	348.83	259.16
EV/FCF Ratio	58.51	88.23	61.66	44.97	134.50	112.91
Debt / Equity Ratio	0.12	0.11	0.11	0.12	0.19	0.29
Debt / EBITDA Ratio	0.55	0.54	0.72	1.18	1.31	1.38
Debt / FCF Ratio	0.48	0.49	0.43	0.56	0.88	0.88
Asset Turnover	0.50	0.44	0.42	0.40	0.38	0.37
Quick Ratio	1.79	1.83	1.69	1.87	1.65	1.50
Current Ratio	1.81	1.86	1.72	1.90	1.71	1.57
Return on Equity (ROE)	16.88%	15.37%	8.36%	2.93%	10.85%	29.81%
Return on Assets (ROA)	5.46%	4.85%	2.70%	1.79%	2.46%	4.02%
Return on Capital (ROIC)	10.38%	9.43%	5.25%	3.39%	5.00%	8.55%
Return on Capital Employed (ROCE)	15.00%	13.20%	8.40%	4.80%	7.00%	11.30%
Earnings Yield	0.98%	0.68%	0.51%	0.24%	0.31%	0.64%
FCF Yield	1.65%	1.10%	1.56%	2.12%	0.73%	0.88%
Buyback Yield / Dilution	-0.67%	-0.35%	-0.05%	-0.28%	-1.77%	-2.47%

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q